标题
HER2 signaling regulates the tumor immune microenvironment and trastuzumab efficacy
作者
关键词
-
出版物
OncoImmunology
Volume -, Issue -, Pages 1-12
出版商
Informa UK Limited
发表日期
2018-09-22
DOI
10.1080/2162402x.2018.1512942
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas
- (2017) Maria Antonella Laginestra et al. MOLECULAR CANCER RESEARCH
- Continuous Delivery of Neutralizing Antibodies Elevate CCL2 Levels in Mice Bearing MCF10CA1d Breast Tumor Xenografts
- (2017) Min Yao et al. Translational Oncology
- RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy
- (2017) Debora Fumagalli et al. JAMA Oncology
- Immune Signatures Following Single Dose Trastuzumab Predict Pathologic Response to PreoperativeTrastuzumab and Chemotherapy in HER2-Positive Early Breast Cancer
- (2016) V. Varadan et al. CLINICAL CANCER RESEARCH
- Predictive biomarkers in the treatment of HER2-positive breast cancer: an ongoing challenge
- (2016) Tiziana Triulzi et al. Future Oncology
- Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
- (2016) N. McGranahan et al. SCIENCE
- A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growth
- (2016) Yogin Patel et al. Oncotarget
- High-density Lipoproteins and Apolipoprotein A-I: Potential New Players in the Prevention and Treatment of Lung Disease
- (2016) Elizabeth M. Gordon et al. Frontiers in Pharmacology
- Immune modulation of pathologic complete response after neoadjuvant HER2-directed therapies in the NeoSphere trial
- (2015) G. Bianchini et al. ANNALS OF ONCOLOGY
- Fhit Nuclear Import Following EGF Stimulation Sustains Proliferation of Breast Cancer Cells
- (2015) Francesca Bianchi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages
- (2015) Yun Shi et al. JOURNAL OF IMMUNOLOGY
- Natural and therapy-induced immunosurveillance in breast cancer
- (2015) Guido Kroemer et al. NATURE MEDICINE
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Clinical relevance of host immunity in breast cancer: from TILs to the clinic
- (2015) Peter Savas et al. Nature Reviews Clinical Oncology
- Genomic correlates of response to CTLA-4 blockade in metastatic melanoma
- (2015) E. M. Van Allen et al. SCIENCE
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Whole-transcriptome analysis links trastuzumab sensitivity of breast tumors to both HER2 dependence and immune cell infiltration
- (2015) Tiziana Triulzi et al. Oncotarget
- Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
- (2015) Kirsten Ridder et al. OncoImmunology
- Activated d16HER2 Homodimers and SRC Kinase Mediate Optimal Efficacy for Trastuzumab
- (2014) L. Castagnoli et al. CANCER RESEARCH
- Research-Based PAM50 Subtype Predictor Identifies Higher Responses and Improved Survival Outcomes in HER2-Positive Breast Cancer in the NOAH Study
- (2014) A. Prat et al. CLINICAL CANCER RESEARCH
- Regulation of cytotoxic T-Lymphocyte trafficking to tumors by chemoattractants: implications for immunotherapy
- (2014) Rajesh K Sharma et al. Expert Review of Vaccines
- The immune system and response to HER2-targeted treatment in breast cancer
- (2014) Giampaolo Bianchini et al. LANCET ONCOLOGY
- Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis
- (2014) Laura Bonapace et al. NATURE
- Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma
- (2014) Alexandra Snyder et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Chemokines in Breast Cancer Pathology and Its Possible Use as Therapeutic Targets
- (2014) M. Isabel Palacios-Arreola et al. Journal of Immunology Research
- CCL2/CCR2-Dependent Recruitment of Functional Antigen-Presenting Cells into Tumors upon Chemotherapy
- (2013) Yuting Ma et al. CANCER RESEARCH
- Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells
- (2013) S. Spranger et al. Science Translational Medicine
- Role of Chemokines and Chemokine Receptors in Shaping the Effector Phase of the Antitumor Immune Response
- (2012) K. Franciszkiewicz et al. CANCER RESEARCH
- MEK Inhibition Leads to PI3K/AKT Activation by Relieving a Negative Feedback on ERBB Receptors
- (2012) A. B. Turke et al. CANCER RESEARCH
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
- (2012) J. M. Taube et al. Science Translational Medicine
- Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
- (2011) Antonis Valachis et al. BREAST
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- Inflammation and cancer: The oncogene-driven connection
- (2008) Maria Grazia Borrello et al. CANCER LETTERS
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
- The tumor microenvironment and its role in promoting tumor growth
- (2008) T L Whiteside ONCOGENE
- Trastuzumab in the Adjuvant Treatment of Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2008) I. J. Dahabreh et al. ONCOLOGIST
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started